Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C49H77FN2O9S |
| Molecular Weight | 889.207 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 15 / 15 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](CF)(CC6)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)NCCN8CCS(=O)(=O)CC8
InChI
InChIKey=GAIICOUZJLZLEU-KLKNJKQTSA-N
InChI=1S/C49H77FN2O9S/c1-30(2)32-12-19-49(51-22-23-52-24-26-62(58,59)27-25-52)21-20-46(6)34(38(32)49)8-9-37-45(5)15-13-33(44(3,4)36(45)14-16-47(37,46)7)31-10-17-48(29-50,18-11-31)43(57)61-42-41(56)40(55)39(54)35(28-53)60-42/h10,13,32,34-42,51,53-56H,1,8-9,11-12,14-29H2,2-7H3/t32-,34+,35+,36-,37+,38+,39+,40-,41+,42-,45-,46+,47+,48+,49-/m0/s1
| Molecular Formula | C49H77FN2O9S |
| Molecular Weight | 889.207 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 15 / 15 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 16:06:11 GMT 2025
by
admin
on
Wed Apr 02 16:06:11 GMT 2025
|
| Record UNII |
CHV9PM6LNM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
167713266
Created by
admin on Wed Apr 02 16:06:11 GMT 2025 , Edited by admin on Wed Apr 02 16:06:11 GMT 2025
|
PRIMARY | |||
|
CHV9PM6LNM
Created by
admin on Wed Apr 02 16:06:11 GMT 2025 , Edited by admin on Wed Apr 02 16:06:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
Forms in bile in high amounts may be recirculated back into plasma.
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Volume of Distribution | PHARMACOKINETIC |
|
|
|||
| Biological Half-life | PHARMACOKINETIC |
|
|
|||